出处
《药品评价》
CAS
2006年第5期391-393,396,共4页
Drug Evaluation
基金
山西省回国留学人员科技项目资助(200470)
山西省科技攻关项目(051092)
参考文献10
-
1Boers W,Aarrass S,Linthors C.Transcriptional profiling re-veals novel markers of liver fibrogenesis:Gremlin and In-sulin-like Growth Factor Binding Proteins[].JBC Papers.2006
-
2Gentilini A,Feliers D,Pinzani M,et al.Characterization andregulation of insulin-like growth factor binding proteins inhuman hepatic stellate cells[]..1998
-
3Paradis V,Dargere D,Bonvoust F,et al.Effects and regula-tion of connective tissue growth factor on hepatic stellate cells[].Laboratory Investigation.2002
-
4Grotendorst1GR,Matthew R.Duncan Individual domains ofconnective tissue growth factor regulate fibroblast prolifera-tion and myofibroblast differentiation[].The FASEB Journal.2005
-
5Li G,Xie Q,Shi Y,et al.Inhibition of connective tissuegrowth factor by siRNA prevents liver fibrosis in rats[].JGene Med.2006
-
6Scharf JG,Dombrowski F,Novosyadlyy R,et al.Insulin-LikeGrowth Factor(IGF)-Binding Protein-1 Is Highly Inducedduring Acute Carbon Tetrachloride Liver Injury and Potenti-ates the IGF-I-Stimulated Activation of Rat Hepatic StellateCells[].The Journal of Endocrinology.2004
-
7Jeschke MG,Herndon DN,Vita R,et al.IGF-I/BP-3 admin-istration preserves hepatic homeostasis after thermal injurywhich is associated with increases in no and hepatic NF-kappa B[].Shock.2002
-
8Paradis V,Dargère,D,Ba N.Connective tissue growth fac-tor(CTGF)expression in experimental and human liver fibro-genesis[].Brith Med J.2001
-
9Novosyadlyy R,Dargel R,Scharf JG.Expression of insulin-like growth factor-Iand insulin-like growth factor binding proteins during thioac-etamide-induced liver cirrhosis in rats[].Growth Horm IGFRes.2005
-
10Paik YH,Schwabe RF,Bataller R,et al.Toll-like receptor 4mediates inflammatory signaling by bacterial lipopolysaccha-ride in human hepatic stellate cells[].Hepatology.2003
同被引文献14
-
1徐珊,包剑锋,周敏,张永生.肝纤维化病证结合模型的研制[J].中国中医药科技,2009,16(2):81-84. 被引量：12
-
2汤艳,郑金旭.热休克蛋白47在肺纤维化中作用及机制的研究[D].江苏大学:儿科学(硕士),2011.
-
3Pandhal J,Ow SY,Noirel J,et al.Improving N-glycosylation efficiency in Escherichia coli using shotgun proteomics,metabolic network analysis,and selective reaction monitoring[J].Biotechnology and Bioengineering,2011,108(4):902-912.
-
4Kumar AP,Nandini CD,Salimath PV.Structural characterization of N-linked oligosaccharides of laminin from rat kidney:changes during diabetes and modulation by dietary fiber and butyric acid[J].FEBS J,2002,78(1):143-155.
-
5Basova IN,Iagodina OV.Comparative sensitivity of liver monoamine oxidases of frog and whitefish to some tricyclic compounds[J].Zh Evol Biokhim Fiziol,2011,47(1):21-26.
-
6恵寿総合病院.血中テストステロンレベル測定は長期作用型LHRHァゴニストの投与間隔を延長できるか?[J].泌尿器科紀要,2010,56(6):301-304.
-
7何涛.熊去氧胆酸联合腺苷蛋氨酸治疗重度淤胆型肝炎的临床疗效观察[J].中外医学研究,2012,10(7):13-14. 被引量：6
-
8龙琴,谭同均,刘影.酒精性肝病患者血中睾酮和雌二醇水平的变化研究[J].检验医学与临床,2012,9(6):655-656. 被引量：2
-
9包剑锋,黄劲松,张永生,徐珊.肝纤维化病证结合模型的研究思路[J].中华中医药学刊,2012,30(4):830-832. 被引量：7
-
10杨志宏,孔令亭,于传亭.吡格列酮对非酒精性脂肪性肝病大鼠血小板源生长因子-B和基质金属蛋白酶抑制因子-2表达的影响[J].中西医结合肝病杂志,2012,22(3):161-164. 被引量：2
-
1覃军,何作云.冠状动脉粥样硬化斑块破裂的细胞与分子生物学研究进展[J].中国动脉硬化杂志,2000,8(1):79-81. 被引量：20
-
2程亚.肝纤维化发病机制的研究进展[J].河南医学研究,2008,17(4):369-371. 被引量：2
-
3张磊,李玉民.肝星状细胞在肝脏疾病中的作用[J].中华消化外科杂志,2014,13(1):73-76. 被引量：5
-
4王治荣.肝非实质性细胞在肝损伤发病机理中的作用[J].日本医学介绍,1994,15(2):66-67.
-
5唐桂连.肝星状细胞与肝纤维化[J].国际消化病杂志,2012,32(5):270-273. 被引量：10
-
6张利利,向晓星.Kupffer细胞在非酒精性脂肪性肝病发病机制中的作用[J].临床肝胆病杂志,2011,27(8):873-876. 被引量：6
-
7赖丽娟.2型糖尿病患者消化系统肿瘤高发的可能机制[J].现代医药卫生,2014,30(18):2876-2877.
-
8张强伟,徐存拴.库普弗细胞的研究进展[J].解剖学报,2010,41(2):331-332.
-
9李秀才.肝细胞生长因子与心力衰竭[J].中医临床研究,2010,2(23):110-112.
-
10李灏,姜颖,贺福初.乙醇肝毒性及治疗的研究进展[J].中国药理学与毒理学杂志,2008,22(5):396-400. 被引量：5
